UriVarx

Innovus Pharmaceuticals

#Other

Safety70

Efficacy50

Transparency68

Based on Examine, Wikipedia, and 23 other sources

Overview

UriVarx is a proprietary herbal blend with moderate evidence supporting its efficacy for overactive bladder symptoms. While a key randomized controlled trial (RCT) demonstrated statistically significant improvements, the proprietary nature of the blend limits the ability to assess individual ingredient dosages and their specific contributions to the overall effect. Further independent and large-scale meta-analyses are needed to solidify its place in bladder health management.

The Good

Clinically studied blend for bladder control: A proprietary blend, often referenced as Urox, which includes the ingredients in UriVarx, has been studied in a Randomized Controlled Trial (RCT) showing benefits for OAB symptoms.

Significant reduction in urinary symptoms: The RCT reported statistically significant improvements in urinary frequency, urgency, nocturia, and incontinence.

Minimal reported side effects: The blend was well-tolerated in clinical studies, suggesting it may be a suitable option for those sensitive to conventional medications.

The Bad

Proprietary blend hides individual ingredient dosages: The exact amounts of Lindera, Horsetail, and Crateva Nurvala are not disclosed, making it impossible to verify if each ingredient is at its clinically effective dose.

Reliance on a single primary clinical study: While a significant RCT exists, more independent and large-scale trials, including meta-analyses, would strengthen the evidence base.

Limited long-term safety data: While short-term safety appears good, the long-term safety profile and potential cumulative effects of the blend are not fully elucidated.